DiaMedica Therapeutics (OTCMKTS:DMCAF) Trading 2.5% Higher

traded during mid-day trading, an increase of 2% from the average session volume of 19,642 shares. The stock has a fifty day simple moving average of $1.44 and a two-hundred day simple moving average of $1.17. DiaMedica Therapeutics Inc. has a 12 month low of $0.72 and a 12 month high of $2.20.

() gained 2.5% in midday trading on Friday. The company traded up to $1.63, and traded last at $1.63. The volume of shares traded at midday was down 85% compared to the average session of 131,151. Stock had closed previously at $1.59.

DiaMedica Therapeutics Price Performance

The company has a simple moving-average of $1.67 for the past 50 days and $1.49 for the last 200 days.

DiaMedica Therapeutics Company profile

Get Rating

DiaMedica Therapeutics Inc is a biopharmaceutical firm in clinical stages that develops treatments for neurological diseases and kidney disease. The company's leading product, DM199, is a recombinant kallikrein-1 human tissue protein that is currently in Phase II clinical studies for acute ischemicstroke and kidney injury indications.

MarketBeat.com offers a FREE daily email newsletter